Nidan Laboratories and Healthcare Limited — Important, 21-11-2025: Updates
21-11-2025 | 12:57 pm
21-11-2025 | 12:57 pm
Nidan Laboratories' board approved H1 FY26 financial results. Revenue from operations reached ₹13.12 Cr, a 24.6% YoY jump. Profit after tax rose to ₹1.43 Cr, up 30.2% YoY. Basic EPS stood at ₹1.03.
No comments yet. Be the first to comment!
All announcements from Nidan Laboratories and Healthcare Limited
